Hualan Biological Engineering Inc. (SHE:002007)
China · Delayed Price · Currency is CNY 14.54
+0.20 (1.39%)
At close: Mar 27, 2026
SHE:002007 Revenue
In the year 2025, Hualan Biological Engineering had annual revenue of 4.60B CNY with 4.93% growth. Hualan Biological Engineering had revenue of 1.22B in the quarter ending December 31, 2025, with 36.87% growth.
Revenue
4.60B
Revenue Growth
+4.93%
P/S Ratio
5.78
Revenue / Employee
1.15M
Employees
4,012
Market Cap
26.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.60B | 215.82M | 4.93% |
| Dec 31, 2024 | 4.38B | -962.68M | -18.02% |
| Dec 31, 2023 | 5.34B | 824.89M | 18.26% |
| Jan 1, 2023 | 4.52B | 80.78M | 1.82% |
| Jan 1, 2022 | 4.44B | -587.01M | -11.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chongqing Zhifei Biological Products | 10.91B |
| Shanghai RAAS Blood Products | 7.35B |
| Beijing Tiantan Biological Products | 6.42B |
| Asymchem Laboratories (Tianjin) | 6.29B |
| Shanghai Allist Pharmaceuticals | 5.17B |
| Yili Chuanning Biotechnology | 4.74B |
| Xiamen Amoytop Biotech | 3.70B |
| Sinocelltech Group | 1.56B |